The Food and Drug Administration authorized extra doses of a COVID-19 vaccine for people with fragile immune systems who were not sufficiently protected after the first vaccination regimen.

“After a thorough review of the available data, the FDA determined that this small, vulnerable group may benefit from a third dose of the Pfizer-BioNTech or Moderna vaccines,” FDA Commissioner Janet Woodcock said.

Recommended Stories

Over 1 million people have obtained COVID-19 booster shots without FDA approval

Biden administration expects smooth COVID booster rollout despite line-cutters

New guidelines will call for third COVID shot for vulnerable people